[OPINION] Refining Our Covid-19 SOPs for the Public – Dr Amar Singh

We need to be science based with our daily SOPs, rather than resort to harsh measures. Heftier fines, extended MCOs, increased public blaming are counterproductive and also harmful to the poor and those that have lost their livelihood. We have to walk this fine balance between harm from Covid-19 and destroying lives from tight SOPs.

[OPINION] Key Measures to Reduce the COVID-19 Raging Fire – Dr Amar Singh

Many individuals and groups have voiced suggestions to manage our raging COVID-19 pandemic in Malaysia. However, few appear to have been considered. Dato’ Dr Amar-Singh HSS summarised five key measures critically needed to take to help put out the COVID-19 raging fire in our nation.

[FEATURE ARTICLE] In Conversation with the 2020 Mahathir Science Award Recipient

This year, the Mahathir Science Award – the most prestigious science award for tropical sciences was presented to Professor Sir Alimuddin Zumla of University College London, in recognition of his exceptional, globally acknowledged research in infectious diseases which is relevant to the development and enhancement of health policy.

[MEDIA RELEASE] All Levels of Society Must Comply with SOPs – AMM

The Academy of Medicine of Malaysia (AMM) urged the government to enforce mandatory quarantine in designated quarantine centres for Sabah returnees. It has been proven in other countries, such as China and Singapore where compliance rates are high, that home quarantines are not as effective in curbing spread.

[MEDIA RELEASE] Impact of COVID-19 on Hepatitis Elimination

Viral hepatitis is a communicable disease that can cause serious liver damage and liver cancer. Deaths from viral hepatitis, the majority (96%) are due to hepatitis B and C, are rising worldwide compared to the downward trend for the other three most common causes of communicable diseases. However, hepatitis is preventable, treatable, and for Hepatitis C, curable with timely treatment.

[MEDIA RELEASE] WHO discontinues hydroxychloroquine and lopinavir/ritonavir treatment arms for COVID-19

These interim trial results show that hydroxychloroquine and lopinavir/ritonavir produce little or no reduction in the mortality of hospitalized COVID-19 patients when compared to standard of care. Solidarity trial investigators will interrupt the trials with immediate effect.

[OPINION] Have we found the panacea to COVID-19 with remdesivir, an old but newly packaged drug?

As of 12 May 2020, 4,425,094 people have been infected with SARS-CoV-2 with deaths reaching 297,723.Doctors are desperately looking for an effective drug, and there have been a number of candidates on trial; one of them, remdesivir, is probably the most exciting of all. This is the drug developed for the Ebola epidemic in 2015, but it was found to be less effective in clinical trials than in in vitro studies. Is remdesivir the panacea for COVID-19?

[EXPERT REACTION] Dexamethasone: Effective Treatment for COVID-19?

A research team at Oxford University has recently found a cheap and widely available drug called dexamethasone that can be used to effectively treat severe forms of COVID-19. The 'breakthrough' drug has shown to significantly reduce the number of deaths among those seriously ill with the coronavirus. We asked experts to comment on the effectiveness of the drug in treating COVID-19.

[MEDIA RELEASE] Stay Vigilant during Recovery MCO – MHC

The Malaysian Health Coalition (MHC) understands and supports the government’s decision to transition into the recovery phase of the movement control order (RMCO). The gradual reopening of public life in Malaysia must rely on appropriate guidance from all areas of government and the Ministry of Health. We must remain vigilant until a vaccine for Covid-19 is available.